Bassendine M F, Collins J D, Stephenson J, Saunders P, James O F
Gut. 1985 Oct;26(10):1074-9. doi: 10.1136/gut.26.10.1074.
Thrombocytopenia in cirrhotic patients is usually attributed to splenic pooling whereas in idiopathic thrombocytopenic purpura it is related to platelet bound immunoglobulin (PA-IgG). Since primary biliary cirrhosis (PBC) is an autoimmune disorder we have undertaken a prospective study to assess the frequency and possible relationship of PA-IgG to thrombocytopenia in this condition. Sixty-two primary biliary cirrhosis patients (28 precirrhotic; 34 cirrhotic) were studied. Twenty-five patients (40%) had raised PA-IgG of whom 18 had cirrhosis. There was a significant inverse correlation between platelet count and PA-IgG (p less than 0.001) and between platelet count and spleen size (p less than 0.001). Thrombocytopenia (platelets less than 100 X 10(9)/l) was found in nine patients (15%); all nine had raised PA-IgG and eight were cirrhotic with an enlarged spleen. Two cirrhotic patients with persistent thrombocytopenia and bleeding episodes were treated with prednisolone and showed a useful therapeutic response. These results suggest that immune mediated platelet destruction and splenic pooling of platelets may both play a part in the thrombocytopenia observed in primary biliary cirrhosis.
肝硬化患者的血小板减少通常归因于脾内血小板滞留,而特发性血小板减少性紫癜患者的血小板减少则与血小板相关免疫球蛋白(PA-IgG)有关。由于原发性胆汁性肝硬化(PBC)是一种自身免疫性疾病,我们进行了一项前瞻性研究,以评估PA-IgG在这种疾病中出现的频率及其与血小板减少的可能关系。我们研究了62例原发性胆汁性肝硬化患者(28例处于肝硬化前期;34例已肝硬化)。25例患者(40%)的PA-IgG升高,其中18例已肝硬化。血小板计数与PA-IgG之间(p<0.001)以及血小板计数与脾脏大小之间(p<0.001)存在显著的负相关。9例患者(15%)出现血小板减少(血小板计数低于100×10⁹/L);所有9例患者的PA-IgG均升高,其中8例已肝硬化且脾脏肿大。2例肝硬化患者出现持续性血小板减少并伴有出血发作,接受泼尼松龙治疗后显示出有效的治疗反应。这些结果表明,免疫介导的血小板破坏和血小板的脾内滞留可能在原发性胆汁性肝硬化患者出现的血小板减少中均起作用。